Macrogenics Q3 EPS $0.28 Beats $(0.10) Estimate, Sales $10.40M Miss $48.86M Estimate
Portfolio Pulse from bharat@benzinga.com
Macrogenics reported Q3 earnings of $0.28 per share, beating the analyst consensus estimate of $(0.10) by 380 percent. However, the company's quarterly sales of $10.40 million missed the analyst consensus estimate of $48.86 million by 78.72 percent.
November 06, 2023 | 9:28 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Macrogenics reported better than expected Q3 earnings but missed on sales. This mixed report could lead to volatility in the stock price.
Macrogenics reported a significant beat on earnings per share, which is a positive signal for the company's profitability. However, the miss on sales indicates lower than expected revenue, which could negatively impact the company's financial health. This mixed report could lead to uncertainty and volatility in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100